Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Armoiry, X.
46  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Efficacy and safety of extracorporeal membrane oxygenation ..:

Pozzi, M ; Metge, A ; Martelin, A...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1358863x20944469.  , 2020
Link: https://www.hal.inserm.f..
 
?
2

Can levosimendan reduce ECMO weaning failure in cardiogenic..:

Guilherme, Enrique ; Jacquet-Lagrèze, M ; Pozzi, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13054-020-03122-y.  , 2020
Link: https://www.hal.inserm.f..
 
?
3

Efficacy and safety of extracorporeal membrane oxygenation ..:

Pozzi, M ; Metge, A ; Martelin, A...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1358863x20944469.  , 2020
Link: https://inserm.hal.scien..
 
?
4

Efficacy and safety of extracorporeal membrane oxygenation ..:

Pozzi, M ; Metge, A ; Martelin, A...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1358863x20944469.  , 2020
Link: https://www.hal.inserm.f..
 
?
5

Can levosimendan reduce ECMO weaning failure in cardiogenic..:

Guilherme, Enrique ; Jacquet-Lagrèze, M ; Pozzi, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13054-020-03122-y.  , 2020
Link: https://www.hal.inserm.f..
 
?
6

Efficacy and safety of extracorporeal membrane oxygenation ..:

Pozzi, M ; Metge, A ; Martelin, A...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1358863x20944469.  , 2020
Link: https://inserm.hal.scien..
 
?
7

Can levosimendan reduce ECMO weaning failure in cardiogenic..:

Guilherme, Enrique ; Jacquet-Lagrèze, M ; Pozzi, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13054-020-03122-y.  , 2020
Link: https://www.hal.inserm.f..
 
?
8

Can levosimendan reduce ECMO weaning failure in cardiogenic..:

Guilherme, E ; Jacquet-Lagrèze, M ; Pozzi, M...
doi:10.1186/s13054-020-03122-y.  , 2020
Link: https://doi.org/10.1186/..
 
?
9

Efficacy and safety of extracorporeal membrane oxygenation ..:

Pozzi, M ; Metge, A ; Martelin, A...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1358863x20944469.  , 2020
Link: https://inserm.hal.scien..
 
?
10

Ocrelizumab for Treating Patients with Primary Progressive ..:

Auguste, P ; Colquitt, J ; Connock, M...
https://discovery.ucl.ac.uk/id/eprint/10092153/3/Ciccarelli_Ocrelizumab%20manuscript%20revised_clean%20R2.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
11

Can levosimendan reduce ECMO weaning failure in cardiogenic..:

Guilherme, Enrique ; Jacquet-Lagrèze, M ; Pozzi, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13054-020-03122-y.  , 2020
Link: https://inserm.hal.scien..
 
?
12

Efficacy and safety of extracorporeal membrane oxygenation ..:

Pozzi, M ; Metge, A ; Martelin, A...
info:eu-repo/semantics/altIdentifier/doi/10.1177/1358863x20944469.  , 2020
Link: https://www.hal.inserm.f..
 
?
13

Can levosimendan reduce ECMO weaning failure in cardiogenic..:

Guilherme, Enrique ; Jacquet-Lagrèze, M ; Pozzi, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13054-020-03122-y.  , 2020
Link: https://www.hal.inserm.f..
 
?
14

Can levosimendan reduce ECMO weaning failure in cardiogenic..:

Guilherme, Enrique ; Jacquet-Lagrèze, M ; Pozzi, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13054-020-03122-y.  , 2020
Link: https://www.hal.inserm.f..
 
?
15

Cost-effectiveness of stent-retriever thrombectomy in large..:

Barral, M ; Armoiry, X ; Boudour, S...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.neurol.2019.06.007.  , 2019
Link: https://hal.science/hal-..
 
1-15